Tevogen Inc.
TVGN
$7.34
$0.010.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.62M | 10.99M | 15.88M | 19.95M | 20.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.40M | 21.19M | 26.14M | 30.89M | 31.25M |
| Operating Income | -21.40M | -21.19M | -26.14M | -30.89M | -31.25M |
| Income Before Tax | -21.61M | -21.35M | -26.28M | -31.04M | -31.20M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.61 | -21.35 | -26.28 | -31.04 | -31.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.61M | -21.35M | -26.28M | -31.04M | -31.20M |
| EBIT | -21.40M | -21.19M | -26.14M | -30.89M | -31.25M |
| EBITDA | -21.28M | -21.00M | -25.95M | -30.72M | -31.04M |
| EPS Basic | -6.98 | -7.17 | -8.81 | -10.87 | -11.11 |
| Normalized Basic EPS | -4.25 | -4.36 | -5.39 | -6.73 | -6.90 |
| EPS Diluted | -6.98 | -7.17 | -8.81 | -10.87 | -11.11 |
| Normalized Diluted EPS | -4.25 | -4.36 | -5.39 | -6.73 | -6.90 |
| Average Basic Shares Outstanding | 13.29M | 12.75M | 12.50M | 12.58M | 12.06M |
| Average Diluted Shares Outstanding | 13.29M | 12.75M | 12.50M | 12.58M | 12.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |